Venous thromboembolism therapy with rivaroxaban in daily-care patients: results from the Dresden NOAC registry
L Keller, S Marten, J Hecker, K Sahin, L Tittl… - International Journal of …, 2018 - Elsevier
The effectiveness and safety of acute venous thromboembolism (VTE) treatment with
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …
rivaroxaban, demonstrated in phase-III trials, needs to be confirmed in daily care. To confirm …
Patterns and predictors of use of anticoagulants for the treatment of venous thromboembolism following approval of rivaroxaban
R Dault, A Vanasse, L Blais… - Clinical and Applied …, 2016 - journals.sagepub.com
Background: Few studies have identified patterns and predictors of use of direct oral
anticoagulants for venous thromboembolism (VTE). Objective: To describe the use of …
anticoagulants for venous thromboembolism (VTE). Objective: To describe the use of …
[HTML][HTML] Rivaroxaban in acute venous thromboembolism: UK prescribing experience
V Speed, JP Patel, D Cooper, S Miller… - Research and practice …, 2021 - Elsevier
Background Rivaroxaban was reported as effective as traditional therapies for the acute
treatment of venous thromboembolism (VTE) with fewer major bleeding complications in the …
treatment of venous thromboembolism (VTE) with fewer major bleeding complications in the …
Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study
P Demelo-Rodríguez, F Galeano-Valle… - Medicine, 2019 - journals.lww.com
Rivaroxaban for the treatment of venous thromboembolism in r... : Medicine Rivaroxaban for the
treatment of venous thromboembolism in real life: A single-center prospective study : Medicine …
treatment of venous thromboembolism in real life: A single-center prospective study : Medicine …
Rivaroxaban for the treatment of venous thromboembolism
N Kucher, D Aujesky, JH Beer… - Thrombosis and …, 2016 - thieme-connect.com
We investigated three-month clinical outcomes in patients with venous thromboembolism
(VTE) treated with rivaroxaban or conventional anticoagulation in routine clinical practice …
(VTE) treated with rivaroxaban or conventional anticoagulation in routine clinical practice …
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism–the J-EINSTEIN DVT and PE program
N Yamada, A Hirayama, H Maeda, S Sakagami… - Thrombosis journal, 2015 - Springer
Abstract Background The global EINSTEIN DVT and PE studies compared rivaroxaban (15
mg twice daily for 3 weeks followed by 20 mg once daily) with enoxaparin/vitamin K …
mg twice daily for 3 weeks followed by 20 mg once daily) with enoxaparin/vitamin K …
Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): analysis of 6-month outcomes
S Gaertner, EM Cordeanu, S Nouri, AM Faller… - International Journal of …, 2017 - Elsevier
Background This study aimed to provide safety and efficacy data of rivaroxaban in routine
patient care in a non-selected symptomatic venous thromboembolism (VTE) population …
patient care in a non-selected symptomatic venous thromboembolism (VTE) population …
Real-Life management of venous thromboembolism with rivaroxaban: results from experience VTe, an Italian epidemiological survey
D Imberti, G Barillari… - Clinical and Applied …, 2018 - journals.sagepub.com
Two large randomized controlled trials examined the efficacy and safety of rivaroxaban for
the treatment of venous thromboembolism (VTE). The aim of this epidemiological study was …
the treatment of venous thromboembolism (VTE). The aim of this epidemiological study was …
Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients
L Jara-Palomares, R Sanchez-Oro-Gomez… - Thrombosis research, 2014 - Elsevier
Introduction Randomized clinical trials have demonstrated non-inferiority of rivaroxaban
compared with vitamin K antagonists (VKAs) in the treatment of venous thromboembolism …
compared with vitamin K antagonists (VKAs) in the treatment of venous thromboembolism …
Oral rivaroxaban for symptomatic venous thromboembolism
Einstein Investigators - New England Journal of Medicine, 2010 - Mass Medical Soc
Background Rivaroxaban, an oral factor Xa inhibitor, may provide a simple, fixed-dose
regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without …
regimen for treating acute deep-vein thrombosis (DVT) and for continued treatment, without …